The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pemetrexed Market Outlook 2024

Global Pemetrexed Market Outlook 2024

Publishing Date : Nov, 2021

License Type :
 

Report Code : 1631624

No of Pages : 103

Synopsis
Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.

The global Pemetrexed market was valued at US$ 1723.2 million in 2020 and is expected to reach US$ 1869.5 million by the end of 2027, growing at a CAGR of 0.7% during 2021-2027.
This report focuses on Pemetrexed volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pemetrexed market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Pemetrexed Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
100mg
500mg

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Eli Lilly
Abbott Laboratories
Cadila Healthcare
Eagle Pharmaceuticals
Stada Arzneimittel
Index
1 Pemetrexed Market Overview
1.1 Product Overview and Scope of Pemetrexed
1.2 Pemetrexed Segment by Type
1.2.1 Global Pemetrexed Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 100mg
1.2.3 500mg
1.3 Pemetrexed Segment by Application
1.3.1 Global Pemetrexed Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pemetrexed Market Size Estimates and Forecasts
1.4.1 Global Pemetrexed Revenue 2016-2027
1.4.2 Global Pemetrexed Sales 2016-2027
1.4.3 Pemetrexed Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pemetrexed Market Competition by Manufacturers
2.1 Global Pemetrexed Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pemetrexed Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pemetrexed Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pemetrexed Manufacturing Sites, Area Served, Product Type
2.5 Pemetrexed Market Competitive Situation and Trends
2.5.1 Pemetrexed Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pemetrexed Players Market Share by Revenue
2.5.3 Global Pemetrexed Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pemetrexed Retrospective Market Scenario by Region
3.1 Global Pemetrexed Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pemetrexed Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pemetrexed Market Facts & Figures by Country
3.3.1 North America Pemetrexed Sales by Country
3.3.2 North America Pemetrexed Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pemetrexed Market Facts & Figures by Country
3.4.1 Europe Pemetrexed Sales by Country
3.4.2 Europe Pemetrexed Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pemetrexed Market Facts & Figures by Region
3.5.1 Asia Pacific Pemetrexed Sales by Region
3.5.2 Asia Pacific Pemetrexed Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pemetrexed Market Facts & Figures by Country
3.6.1 Latin America Pemetrexed Sales by Country
3.6.2 Latin America Pemetrexed Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pemetrexed Market Facts & Figures by Country
3.7.1 Middle East and Africa Pemetrexed Sales by Country
3.7.2 Middle East and Africa Pemetrexed Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pemetrexed Historic Market Analysis by Type
4.1 Global Pemetrexed Sales Market Share by Type (2016-2021)
4.2 Global Pemetrexed Revenue Market Share by Type (2016-2021)
4.3 Global Pemetrexed Price by Type (2016-2021)

5 Global Pemetrexed Historic Market Analysis by Application
5.1 Global Pemetrexed Sales Market Share by Application (2016-2021)
5.2 Global Pemetrexed Revenue Market Share by Application (2016-2021)
5.3 Global Pemetrexed Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Pemetrexed Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Eli Lilly Pemetrexed Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Pemetrexed Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Laboratories Pemetrexed Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Cadila Healthcare
6.3.1 Cadila Healthcare Corporation Information
6.3.2 Cadila Healthcare Description and Business Overview
6.3.3 Cadila Healthcare Pemetrexed Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cadila Healthcare Pemetrexed Product Portfolio
6.3.5 Cadila Healthcare Recent Developments/Updates
6.4 Eagle Pharmaceuticals
6.4.1 Eagle Pharmaceuticals Corporation Information
6.4.2 Eagle Pharmaceuticals Description and Business Overview
6.4.3 Eagle Pharmaceuticals Pemetrexed Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Eagle Pharmaceuticals Pemetrexed Product Portfolio
6.4.5 Eagle Pharmaceuticals Recent Developments/Updates
6.5 Stada Arzneimittel
6.5.1 Stada Arzneimittel Corporation Information
6.5.2 Stada Arzneimittel Description and Business Overview
6.5.3 Stada Arzneimittel Pemetrexed Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Stada Arzneimittel Pemetrexed Product Portfolio
6.5.5 Stada Arzneimittel Recent Developments/Updates

7 Pemetrexed Manufacturing Cost Analysis
7.1 Pemetrexed Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pemetrexed
7.4 Pemetrexed Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pemetrexed Distributors List
8.3 Pemetrexed Customers

9 Pemetrexed Market Dynamics
9.1 Pemetrexed Industry Trends
9.2 Pemetrexed Growth Drivers
9.3 Pemetrexed Market Challenges
9.4 Pemetrexed Market Restraints

10 Global Market Forecast
10.1 Pemetrexed Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pemetrexed by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pemetrexed by Type (2022-2027)
10.2 Pemetrexed Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pemetrexed by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pemetrexed by Application (2022-2027)
10.3 Pemetrexed Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pemetrexed by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pemetrexed by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Pemetrexed Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pemetrexed Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Pemetrexed Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pemetrexed Covered in This Study
Table 5. Global Pemetrexed Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Pemetrexed Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pemetrexed Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pemetrexed Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pemetrexed Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pemetrexed Manufacturing Sites and Area Served
Table 11. Manufacturers Pemetrexed Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pemetrexed by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pemetrexed as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pemetrexed Sales by Region (2016-2021) & (Units)
Table 16. Global Pemetrexed Sales Market Share by Region (2016-2021)
Table 17. Global Pemetrexed Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pemetrexed Sales by Country (2016-2021) & (Units)
Table 19. North America Pemetrexed Sales Market Share by Country (2016-2021)
Table 20. North America Pemetrexed Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pemetrexed Revenue Market Share by Country (2016-2021)
Table 22. Europe Pemetrexed Sales by Country (2016-2021) & (Units)
Table 23. Europe Pemetrexed Sales Market Share by Country (2016-2021)
Table 24. Europe Pemetrexed Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pemetrexed Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pemetrexed Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Pemetrexed Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pemetrexed Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pemetrexed Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pemetrexed Sales by Country (2016-2021) & (Units)
Table 31. Latin America Pemetrexed Sales Market Share by Country (2016-2021)
Table 32. Latin America Pemetrexed Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pemetrexed Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pemetrexed Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Pemetrexed Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pemetrexed Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pemetrexed Revenue Market Share by Country (2016-2021)
Table 38. Global Pemetrexed Sales (Units) by Type (2016-2021)
Table 39. Global Pemetrexed Sales Market Share by Type (2016-2021)
Table 40. Global Pemetrexed Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pemetrexed Revenue Share by Type (2016-2021)
Table 42. Global Pemetrexed Price (USD/Unit) by Type (2016-2021)
Table 43. Global Pemetrexed Sales (Units) by Application (2016-2021)
Table 44. Global Pemetrexed Sales Market Share by Application (2016-2021)
Table 45. Global Pemetrexed Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pemetrexed Revenue Share by Application (2016-2021)
Table 47. Global Pemetrexed Price (USD/Unit) by Application (2016-2021)
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Business Overview
Table 50. Eli Lilly Pemetrexed Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Eli Lilly Pemetrexed Product
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Abbott Laboratories Corporation Information
Table 54. Abbott Laboratories Description and Business Overview
Table 55. Abbott Laboratories Pemetrexed Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Abbott Laboratories Pemetrexed Product
Table 57. Abbott Laboratories Recent Developments/Updates
Table 58. Cadila Healthcare Corporation Information
Table 59. Cadila Healthcare Description and Business Overview
Table 60. Cadila Healthcare Pemetrexed Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Cadila Healthcare Pemetrexed Product
Table 62. Cadila Healthcare Recent Developments/Updates
Table 63. Eagle Pharmaceuticals Corporation Information
Table 64. Eagle Pharmaceuticals Description and Business Overview
Table 65. Eagle Pharmaceuticals Pemetrexed Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Eagle Pharmaceuticals Pemetrexed Product
Table 67. Eagle Pharmaceuticals Recent Developments/Updates
Table 68. Stada Arzneimittel Corporation Information
Table 69. Stada Arzneimittel Description and Business Overview
Table 70. Stada Arzneimittel Pemetrexed Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Stada Arzneimittel Pemetrexed Product
Table 72. Stada Arzneimittel Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Pemetrexed Distributors List
Table 76. Pemetrexed Customers List
Table 77. Pemetrexed Market Trends
Table 78. Pemetrexed Growth Drivers
Table 79. Pemetrexed Market Challenges
Table 80. Pemetrexed Market Restraints
Table 81. Global Pemetrexed Sales Forecast by Type (2022-2027) & (Units)
Table 82. Global Pemetrexed Sales Market Share Forecast by Type (2022-2027)
Table 83. Global Pemetrexed Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 84. Global Pemetrexed Revenue Market Share Forecast by Type (2022-2027)
Table 85. Global Pemetrexed Sales Forecast by Application (2022-2027) & (Units)
Table 86. Global Pemetrexed Sales Market Share Forecast by Application (2022-2027)
Table 87. Global Pemetrexed Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 88. Global Pemetrexed Revenue Market Share Forecast by Application (2022-2027)
Table 89. Global Pemetrexed Sales Forecast by Region (2022-2027) & (Units)
Table 90. Global Pemetrexed Sales Market Share Forecast by Region (2022-2027)
Table 91. Global Pemetrexed Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 92. Global Pemetrexed Revenue Market Share Forecast by Region (2022-2027)
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pemetrexed
Figure 2. Global Pemetrexed Market Share by Type in 2020 & 2027
Figure 3. 100mg Product Picture
Figure 4. 500mg Product Picture
Figure 5. Global Pemetrexed Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Pemetrexed Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Pemetrexed Market Size 2016-2027 (US$ Million)
Figure 11. Global Pemetrexed Sales 2016-2027 (Units)
Figure 12. Global Pemetrexed Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Pemetrexed Sales Share by Manufacturers in 2020
Figure 14. Global Pemetrexed Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Pemetrexed Players: Market Share by Revenue in 2020
Figure 16. Pemetrexed Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Pemetrexed Sales Market Share by Region (2016-2021)
Figure 18. Global Pemetrexed Sales Market Share by Region in 2020
Figure 19. Global Pemetrexed Revenue Market Share by Region (2016-2021)
Figure 20. Global Pemetrexed Revenue Market Share by Region in 2020
Figure 21. U.S. Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Pemetrexed Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Pemetrexed by Type (2016-2021)
Figure 46. Sales Market Share of Pemetrexed by Application (2016-2021)
Figure 47. Sales Market Share of Pemetrexed by Application in 2020
Figure 48. Revenue Share of Pemetrexed by Application (2016-2021)
Figure 49. Revenue Share of Pemetrexed by Application in 2020
Figure 50. Manufacturing Cost Structure of Pemetrexed
Figure 51. Manufacturing Process Analysis of Pemetrexed
Figure 52. Pemetrexed Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’